About Us
Who We Are
We at Elev8Evidence are a boutique consulting agency dedicated to driving value and enhancing access for life science companies through the power of impactful evidence. We empower our clients to transcend boundaries and redefine value through the compelling influence of rigorous evidence, strategic thinking and innovation. With a commitment to scientific rigor and a deep understanding of the healthcare landscape, we help our clients navigate the complex journey of bringing new products to market and optimizing therapy success across the life cycle.
Elev8Evidence Leadership team
Gary Schneider, ScD, MSPH
Phillip Hivale, PharmD, MBA
Gary Schneider, ScD, MSPH
Chief Executive Officer
Gary has a proven track record of providing senior scientific and strategic support on real-world data (RWD) study design and analysis to produce actionable real-world evidence (RWE). He has 30-years applied epidemiology and biostatistics experience, including nearly 25-years with retrospective database study desig
Chief Executive Officer
Gary has a proven track record of providing senior scientific and strategic support on real-world data (RWD) study design and analysis to produce actionable real-world evidence (RWE). He has 30-years applied epidemiology and biostatistics experience, including nearly 25-years with retrospective database study design and analysis, and 20-years directly supporting pharmaceutical and medical device organizations.
Kathy Belk, BA
Phillip Hivale, PharmD, MBA
Gary Schneider, ScD, MSPH
Chief Operations Officer
Kathy is a clinical informaticist, data scientist and healthcare technologist with over 25 years of experience conducting healthcare research and performance improvement initiatives. She has a passion to transform healthcare through data-driven care redesign and a diverse background enabling her to balance innovati
Chief Operations Officer
Kathy is a clinical informaticist, data scientist and healthcare technologist with over 25 years of experience conducting healthcare research and performance improvement initiatives. She has a passion to transform healthcare through data-driven care redesign and a diverse background enabling her to balance innovative strategy with rigorous scientific methodologies to create fit-for-purpose solutions.
Aaron Mendelsohn, PhD, MPH
Phillip Hivale, PharmD, MBA
Phillip Hivale, PharmD, MBA
Chief Scientific Officer
Aaron is an epidemiologist specializing in pharmaceutical risk management, disease and drug-based registries, infectious disease epidemiology, patient preferences and patient-reported outcomes, and epidemiological methods.
Aaron has consulted for a variety of pharmaceutical and biotechnology companies and has d
Chief Scientific Officer
Aaron is an epidemiologist specializing in pharmaceutical risk management, disease and drug-based registries, infectious disease epidemiology, patient preferences and patient-reported outcomes, and epidemiological methods.
Aaron has consulted for a variety of pharmaceutical and biotechnology companies and has delivered numerous webinars and training courses to regulators and international audiences.
Phillip Hivale, PharmD, MBA
Phillip Hivale, PharmD, MBA
Phillip Hivale, PharmD, MBA
Chief Strategy Officer
Phillip has 12+ years in market access, managed markets, payer engagement, value-based contracting, regulatory policies, pricing and reimbursement, brand strategy, and health and economic outcomes. He has collaborated alongside numerous stakeholders and formulary decision-makers across payers and health systems.
Chief Strategy Officer
Phillip has 12+ years in market access, managed markets, payer engagement, value-based contracting, regulatory policies, pricing and reimbursement, brand strategy, and health and economic outcomes. He has collaborated alongside numerous stakeholders and formulary decision-makers across payers and health systems. He provides specializations in access strategy and differentiated value/access messaging.